Elaine Barros Ferreira

Elaine Barros Ferreira

Auto-generated profile, based on publicly available information

Elaine Barros Ferreira

Universidade de Brasília, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
FCFlávia Oliveira Almeida Marques Cruz
Flávia Oliveira Almeida Marques Cruz
RVRicardo Alencar Vilela
Ricardo Alencar Vilela
EFElaine Barros Ferreira
Elaine Barros Ferreira
NMNilce Santos Melo
Nilce Santos Melo
PRPaula Elaine Diniz Dos Reis
Paula Elaine Diniz Dos Reis
Background: Cancer is a major cause of morbidity, disability, and mortality worldwide, and breast cancer is the most common cause of death in women. Different modalities of cancer treatment can have adverse effects that reduce the quality of life of patients and lead to treatment interruptions, if not managed properly. The use of mobile technologies has brought innovative possibilities for improving health care. Mobile apps can help individuals manage their own health and well-being and may also promote healthy lifestyles and information access. Objective: The aim of this study was to identify available evidence on the use of mobile apps to provide information and facilitate communication regarding self-care management related to the adverse effects of toxicities owing to breast cancer therapy. Methods: This systematic review includes studies which were identified using a search strategy adapted for each electronic database: CINAHL, Cochrane Library, LILACS, LIVIVO, PubMed, SCOPUS, and Web of Science. In addition, a gray literature search was performed using Google Scholar. All the electronic database searches were conducted on April 17, 2019. Two investigators independently reviewed the titles and abstracts of the studies identified and then read the full text of all selected papers. The quality of the included studies was analyzed by the Cochrane Collaboration Risk of Bias Tool and the Methodological Index for Non-Randomized Studies. Results: A total of 9 studies which met the eligibility criteria—3 randomized clinical trials and 6 nonrandomized studies published in English from 2010 to 2018—were considered for this systematic review; 396 patients with breast cancer, as well as 40 experts in the medical and nursing fields, and 3 software engineers were included. Conclusions: The evidence from the studies included in this systematic review is currently limited but suggests that mobile apps for women with breast cancer might be an acceptable information source that can improve patient well-being; they can also be used to report symptoms and adverse treatment-related effects and promote self-care. There is a need to test more evidence-based apps in future randomized clinical trials.

12 December 2016 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
EFElaine Barros Ferreira
Elaine Barros Ferreira
CVChristiane Inocêncio Vasques
Christiane Inocêncio Vasques
RGRafael Gadia
Rafael Gadia
RCRaymond J. Chan
Raymond J. Chan
EGEliete Neves Silva Guerra
Eliete Neves Silva Guerra
PRPaula Elaine Diniz dos Reis
Paula Elaine Diniz dos Reis

1 January 2021 in Revista da Escola de Enfermagem da USP
Verified
Journal Article
Open access
PDF file
PBPriscila de Souza Maggi Bontempo
Priscila de Souza Maggi Bontempo
MCMarcia Aparecida Ciol
Marcia Aparecida Ciol
AMAmanda Gomes de Menêses
Amanda Gomes de Menêses
GSGiovana Paula Rezende Simino
Giovana Paula Rezende Simino
EFElaine Barros Ferreira
Elaine Barros Ferreira
PRPaula Elaine Diniz dos Reis
Paula Elaine Diniz dos Reis
Objective: To estimate the incidence and distribution of the degree of radiodermatitis in cancer patients submitted to radiotherapy in the regions of head and neck, breast, and pelvis. Method: Prospective, longitudinal, quantitative study conducted from March 15, 2016 to May 4, 2017 with patients observed for five weeks of treatment. The primary outcome was the proportion of grade 1 or higher radiodermatitis each week. The degree of radiodermatitis and mean time of occurrence for each patient were secondary outcomes. Results: This study included 112 patients. The incidence of radiodermatitis was 100% among those whose head and neck region was irradiated, followed by 98% for breast and 48% for the pelvic region. The degree of radiodermatitis varied with the irradiated site; the worst degrees were found in the head and neck region, followed by the breast. In the three groups, the mean time of the first occurrence of radiodermatitis was approximately eleven days. Conclusion: The incidence of radiodermatitis in the studied groups was high, which reinforces the need to perform the same evaluation nationwide. This would support creating and standardizing protocols and recommendations for a proper management of radiodermatitis, specially concerning its prevention.

1 January 2020 in Integrative Cancer Therapies
Verified
Journal Article
Open access
PDF file
EFElaine B. Ferreira
Elaine B. Ferreira
MCMarcia A. Ciol
Marcia A. Ciol
AMAmanda G. de Meneses
Amanda G. de Meneses
PBPriscila de S. M. Bontempo
Priscila de S. M. Bontempo
JHJeanne M. Hoffman
Jeanne M. Hoffman
PRPaula E. D. dos Reis
Paula E. D. dos Reis
We assessed safety and potential efficacy of a chamomile gel compared with urea cream to prevent acute radiation dermatitis in head and neck cancer patients. We assessed safety and potential efficacy of the chamomile gel in escalating concentrations of 2.50%, 5.00% and 8.35% of chamomile. Concentration of 8.35% was chosen for a randomized trial comparing chamomile gel (8.35%) with urea cream (n = 24 per group), for potential efficacy to delay or prevent radiation dermatitis in these patients. Preliminary results demonstrate a delayed onset of dermatitis, with onset of Grade 2 dermatitis at 5.1 (1.3) weeks in the chamomile group and 4.5 (1.3) weeks in the urea group (effect size of 0.46). Itching, burning and hyperpigmentation were more frequently reported in the urea group. Results indicates a potential efficacy of the chamomile gel. Further studies are needed to confirm the effect of the chamomile gel in reducing or delaying the occurrence of radiation dermatitis.

7 May 2018 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
PDF file
AMAmanda Gomes de Menêses
Amanda Gomes de Menêses
PRPaula Elaine Diniz dos Reis
Paula Elaine Diniz dos Reis
EGEliete Neves Silva Guerra
Eliete Neves Silva Guerra
GCGraziela De Luca Canto
Graziela De Luca Canto
EFElaine Barros Ferreira
Elaine Barros Ferreira
Objective: to evaluate the effects of trolamine in the prevention or treatment of radiation dermatitis. Method: systematic review and meta-analysis. Detailed individual search strategies for Cinahl, Cochrane Library Central, LILACS, PubMed, and Web of Science were developed in January 2016. A manual search was also performed to find additional references. A grey literature search was executed by using Google Scholar. Two researchers independently read the titles and abstracts from every cross-reference. The risk of bias of the included studies was analyzed by the Cochrane Collaboration Risk of Bias Tool. The quality of evidence and grading of strength of recommendations was assessed using Grades of Recommendation, Assessment, Development and Evaluation (GRADE). Results: seven controlled clinical trials were identified. The controls used were calendula, placebo, institutional preference / usual care, Aquaphor®, RadiaCare™, and Lipiderm™. The studies were pooled using frequency of events and risk ratio with 95% confidence intervals, in subgroups according to radiation dermatitis graduation. Conclusion: based on the studies included in this review, trolamine cannot be considered as a standardized product to prevent or treat radiation dermatitis in patients with breast and head and neck cancer.

1 June 2021 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
BABeatriz Regina Lima de Aguiar
Beatriz Regina Lima de Aguiar
EGEliete Neves Silva Guerra
Eliete Neves Silva Guerra
ANAna Gabriela Normando
Ana Gabriela Normando
CMCarolina Martins
Carolina Martins
PRPaula Elaine Diniz dos Reis
Paula Elaine Diniz dos Reis
EFElaine Barros Ferreira
Elaine Barros Ferreira